A therapeutic regimen using LPNP-p198 followed by gemcitabine thereby effectively inhibits tumor cell proliferation and induces tumor cell apoptosis in an orthotopic PDAC mouse model through miR-198-mediated VCP regulation. Here, VCP is linked to neoplasm.